Ginkgo Bioworks Inc.

NYSE: DNA · Real-Time Price · USD
13.12
0.22 (1.71%)
At close: Aug 15, 2025, 3:46 PM

Ginkgo Bioworks Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
227.04M 251.46M 477.71M 313.84M
Cost of Revenue
38.55M 54.01M 204.22M 129.69M
Gross Profit
188.49M 197.45M 273.49M 184.15M
Operating Income
-559.76M -864.41M -2.21B -1.83B
Interest Income
38.61M 57.22M 20.26M 837K
Pretax Income
-547.51M -892.94M -2.12B -1.84B
Net Income
-547.03M -892.87M -2.1B -1.83B
Selling & General & Admin
246.16M 385.02M 1.43B 862.95M
Research & Development
424.06M 580.62M 1.05B 1.15B
Other Expenses
78.03M 96.21M n/a n/a
Operating Expenses
748.25M 1.06B 2.48B 2.01B
Interest Expense
94K 93K 106K 2.37M
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
786.8M 1.12B 2.69B 2.14B
Income Tax Expense
-479K -71K -15.03M -1.48M
Shares Outstanding (Basic)
51.89M 48.53M 41.93M 32.95M
Shares Outstanding (Diluted)
51.89M 48.61M 42M 34.01M
EPS (Basic)
-10.54 -18.37 -50.15 -53.83
EPS (Diluted)
-10.54 -18.4 -50.2 -55.53
EBITDA
-484.39M -821.29M -2.06B -1.81B
EBIT
-547.41M -892.85M -2.12B -1.84B
Depreciation & Amortization
63.02M 71.55M 61.63M 29.08M